Table 1 Demographics of mesothelioma patients.

From: Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China

Variables

n (%)

Median OS (months)

95% CI

χ2

P

Overall survival

82 (100)

12.5

10.5–18.0

–

–

Gender

Male

21 (25.6)

10.5

9.5–26

0.0

0.886

Female

61 (74.4)

14.0

11–19.5

  

Age

 < 60 years

50 (61.0)

15

12–21

2.9

0.089

 ≥ 60 years

32 (39.0)

10.5

7.3–13

  

Subtype

Epithelioid

74 (90.2)

12.5

10–18

0.0

0.879

Non-epithelioida

8 (9.8)

10.5

9.6–26.8

  

Site

Pleural

31 (37.8)

12

9.5–21

0.1

0.748

Peritoneal

51 (62.2)

14.3

8–19.5

  

Treatment

Surgeryb

63 (72.4)

12.5

9.5–18

0.2

0.640

Non-surgeryc

24 (27.6)

12

10.5–24

  
  1. OS: overall survival.
  2. aIncluding the patients with biphasic or sarcomatoid subtype.
  3. bIncluding the patients undergoing chemotherapy after surgery.
  4. cIncluding the patients undergoing chemotherapy, radiotherapy or no special treatment.
Back to article page